The following is a summary of “Plasma Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers of Cognitive Decline in People With Human Immunodeficiency Virus,” published in the ...

Changes in cerebrospinal fluid (CSF) neurofilament light (NfL) protein and proenkephalin (PENK) emerged decades before ...

Background and aims The performance of neurodegenerative biomarkers-neurofilament light chain (NfL), glial fibrillary acidic ...

A study reveals subtle neurodegenerative changes in people with Huntington’s disease gene expansion up to 20 years before ...

A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in ...

They also found more subtle declines in dexterity and cognition. The researchers found that a biomarker in the blood called ...

DNLI's DNL343 fails to achieve the primary and secondary endpoints, as observed from an analysis of Regimen G of the phase II ...

Primary endpoint of overall function (ALSFRS-R) and survival, and key secondary endpoints of muscle strength and respiratory function, were not met at 24 weeksOverall, DNL343 was found to be safe and ...

Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...

Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen approximately 20 ...

Stock futures were mixed in Tuesday’s premarket session as investors looked ahead to the release of the Job Openings and ...